Abiopharma

🔍 Zamarro Christina L (Director)

Company: L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX)

Report Date: 2026-05-11

Detailed Transactions and Holdings:

• Acquired 661 shares of Common Stock, Par Value $1.00 (Direct)
  Date: 2026-05-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,114.89 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents an award of director share units in respect of the non-employee director's equity-based retainer, which generally will vest on May 11, 2027, subject to the non-employee director's continued service and the terms and conditions of the director share unit agreement. Pursuant to a prior election to defer such units upon vesting, such units will be settled in shares of common of stock upon the reporting person's separation from service with the Issuer.
• REMARKS: Exhibit List: Exhibit 24- Power of Attorney